Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Quantity versus quality: optimal methods for cell-free DNA isolation from plasma of pregnant women.

Jorgez CJ, Dang DD, Simpson JL, Lewis DE, Bischoff FZ.

Genet Med. 2006 Oct;8(10):615-9.

PMID:
17079877
2.

The Most Favourable Procedure for the Isolation of Cell-Free DNA from the Plasma of Iso-Immunized RHD-Negative Pregnant Women.

Rather RA, Saha SC, Dhawan V.

J Circ Biomark. 2015 Dec 9;4:12. doi: 10.5772/62113. eCollection 2015 Jan-Dec.

3.

Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR.

Johnson KL, Dukes KA, Vidaver J, LeShane ES, Ramirez I, Weber WD, Bischoff FZ, Hahn S, Sharma A, Dang DX, Hire LM, Bianchi DW, Simpson JL, Holzgreve W, Elias S, Klinger KW.

Clin Chem. 2004 Mar;50(3):516-21. Epub 2004 Jan 12.

4.

Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification.

Jorgez CJ, Bischoff FZ.

Fetal Diagn Ther. 2009;25(3):314-9. doi: 10.1159/000235877. Epub 2009 Sep 22.

5.

Selection of the optimal manual method of cell free fetal DNA isolation from maternal plasma.

Repiská G, Sedláčková T, Szemes T, Celec P, Minárik G.

Clin Chem Lab Med. 2013 Jun;51(6):1185-9. doi: 10.1515/cclm-2012-0418.

PMID:
23241606
6.

Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma.

Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, Lo YM.

Clin Chem. 2001 Sep;47(9):1607-13.

7.

Microsystem for isolation of fetal DNA from maternal plasma by preparative size separation.

Hahn T, Drese KS, O'Sullivan CK.

Clin Chem. 2009 Dec;55(12):2144-52. doi: 10.1373/clinchem.2009.127480. Epub 2009 Oct 1.

8.

Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.

Liu FM, Wang XY, Feng X, Wang W, Ye YX, Chen H.

Acta Obstet Gynecol Scand. 2007;86(5):535-41.

PMID:
17464580
9.

A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.

Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B.

Prenat Diagn. 2006 Sep;26(9):831-6.

PMID:
16832830
10.

Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction.

Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, Farina A.

Am J Obstet Gynecol. 2003 Feb;188(2):480-4.

PMID:
12592259
11.

Quantification of fetal DNA by use of methylation-based DNA discrimination.

Nygren AO, Dean J, Jensen TJ, Kruse S, Kwong W, van den Boom D, Ehrich M.

Clin Chem. 2010 Oct;56(10):1627-35. doi: 10.1373/clinchem.2010.146290. Epub 2010 Aug 20.

12.

Methods to increase the percentage of free fetal DNA recovered from the maternal circulation.

Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood M, Cronin M, Chou V, Mohr M.

JAMA. 2004 Mar 3;291(9):1114-9.

PMID:
14996781
13.

Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.

van den Oever JM, Balkassmi S, Segboer T, Verweij EJ, van der Velden PA, Oepkes D, Bakker E, Boon EM.

PLoS One. 2013 Dec 31;8(12):e84051. doi: 10.1371/journal.pone.0084051. eCollection 2013.

14.

Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma.

Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S.

JAMA. 2005 Feb 16;293(7):843-9. Erratum in: JAMA. 2005 Apr 13;293(14):1728.

PMID:
15713774
15.

Size distributions of maternal and fetal DNA in maternal plasma.

Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YM.

Clin Chem. 2004 Jan;50(1):88-92.

16.

Improvement of methods for the isolation of cell-free fetal DNA from maternal plasma: comparison of a manual and an automated method.

Huang DJ, Zimmermann BG, Holzgreve W, Hahn S.

Ann N Y Acad Sci. 2006 Sep;1075:308-12.

PMID:
17108225
17.

Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM.

Am J Hum Genet. 1998 Apr;62(4):768-75.

18.

Specific magnetic bead-based capture of free fetal DNA from maternal plasma.

Legler TJ, Liu Z, Heermann KH, Hempel M, Gutensohn K, Kiesewetter H, Pruss A.

Transfus Apher Sci. 2009 Jun;40(3):153-7. doi: 10.1016/j.transci.2009.03.003. Epub 2009 Apr 11.

PMID:
19364676
19.

[Quantity of total cell free and cell free fetal DNA in pregnancies with no complications and with preeclampsia].

Lázár L, Nagy B, Molvarec A, Rigó J Jr.

Orv Hetil. 2010 May 9;151(19):784-7. doi: 10.1556/OH.2010.28784. Hungarian.

PMID:
20427261
20.

Intact fetal cell isolation from maternal blood: improved isolation using a simple whole blood progenitor cell enrichment approach (RosetteSep).

Bischoff FZ, Marquéz-Do DA, Martinez DI, Dang D, Horne C, Lewis D, Simpson JL.

Clin Genet. 2003 Jun;63(6):483-9.

PMID:
12786755

Supplemental Content

Support Center